Healthcare Professionals — SEE THE NEW DERMATHERAPY HEALTHCARE SITE!


       

HOW IT WORKS

For a dry, restful sleep, DermaTherapy® Bedding combats the problem of night sweats and moisture by treating the sleeping surface rather than the body. Uniquely structured micro-fibers channel moisture away from the skin and distribute it evenly over the surface of the sheet. As moisture evaporates, the wetness and clamminess associated with night sweats and hot flashes is reduced. For menopausal women, the result is a comfortable sleeping surface that stays dry and cool throughout the night.

  • The uniquely structured fibers create thin channels that wick moisture away and dry skin more quickly.
  • DermaTherapy® Bedding is designed to be smooth and soft - minimizing friction with the skin, unlike cotton sheets.

Durable antimicrobial treatment helps maintain freshness and eliminates odors on the fabric caused by germs and bacteria.

A PROVEN DIFFERENCE

Recent independent studies show that DermaTherapy® Bedding can effectively relieve the discomfort associated with night sweats and hot flashes. In 2007, Northeast Surgical Associates of Ohio, LTD evaluated the efficacy of DermaTherapy® bedding to control night sweats and improve the quality of life for 28 postmenopausal women. Over a period of eight weeks, the women were asked to sleep on DermaTherapy Bedding and record their experience. 

A COMPREHENSIVE ANALYSIS

Two evaluation tools were used in the study. The first, the Pittsburgh Sleep Quality Index (PSQI), is a questionnaire designed to assess sleep quality. Consisting of seven components, the PSQI measures sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction.

The secondary form of evaluation is a Quality of Life (QOL) assessment that measures an individual's ability to keep cool, amount of sweating and perceived comfort while using DermaTherapy® Bedding.

COMPELLING RESULTS

For many menopausal women, the benefits of DermaTherapy® Bedding were immediately apparent. Initially, most participants had a mean global PSQI score of almost 9 - characterizing them as "poor sleepers". After using DermaTherapy® bedding for 4 and 8 weeks, global PSQI scores improved dramatically. As shown, the average scores indicate that study participants moved into the category of "good" sleepers by Week Eight.

       

DermaTherapy® bedding also affected scores in a majority of the PSQI components. By weeks four and eight, Subjective Sleep Quality, Sleep Latency, Sleep Duration, Sleep Disturbances and Daytime Dysfunction had seen dramatic improvements.

This research is available for further reading at:

THERAPEUTIC BEDDING - A NIGHTTIME INTERVENTION FOR MENOPAUSE THERAPEUTIC BEDDING - A NIGHTTIME INTERVENTION FOR MENOPAUSE (1040 KB)

 

© 2017 DermaTherapy is a registered trademark of Precision Fabrics Group, Inc. · Terms & Conditions · Privacy policy · All Rights Reserved · Questions? Call us toll free at 844-DERMA-44.